![Sample our Earth Sciences journals, sign in here to start your access, latest two full volumes FREE to you for 14 days]({"type":"image" , "src" : "/sda/5930/TOC-Subject-Sample-2021-Earth-Sciences.jpg"})
Financial & competing interests disclosure
Vance G Fowler Jr was supported in part by R01-AI068804. This work was supported by The Danish Heart Foundation (grant 08-10-68-A2155-B778-22512). The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.
The correct disclosure is shown below:
Financial & competing interests disclosure
Vance G Fowler Jr was supported in part by R01-AI068804. This work was supported by The Danish Heart Foundation (grant 08-10-68-A2155-B778-22512). Dr Fowler also receives grant or research support from Astellas, Cubist, Merck, Theravance, Cerexa, Pfizer, Novartis and Advanced Liquid Logic. He is a paid consultant for Astellas, Cubist, Inhibitex, Merck, Johnson & Johnson, Leo Pharmaceuticals, NovaDigm, The Medicines Company, Baxter Pharmaceuticals and Biosynexus. Dr Fowler is on the speaker‘s bureau and advisory committee for Cubist and has received honoraria from Arpida, Astellas, Cubist, Inhibitex, Merck, Pfizer, Targanta, Theravance, Wyeth, Ortho-McNeil, Novartis and Vertex Pharmaceuticals. Niels Bruun is a paid consultant for Leo Pharmaceuticals and has receieved honoraria from Novartis, Pfizer and Roche. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.
The editors of Future Microbiology would like to sincerely apologize for any inconvenience or confusion this may have caused our readers.